Breast implant retrospective registry
This article was originally published in The Gray Sheet
Executive Summary
Current and former breast implant manufacturers met with device center staffers Feb. 9 to discuss development of the registry. Firms including Dow Corning, Mentor, Baxter Healthcare, Bioplasty, McGhan parent Inamed, Bristol- Myers Squibb and Surgitek are formulating plans to create a voluntary registry that would operate using industry funds. Discussions of the registry were initiated by FDA in April in response to the silicone gel-filled breast implant controversy ("The Gray Sheet" April 20, 1992, p. 1).